TOTakehito Otsubo

Takehito Otsubo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takehito Otsubo has a total of 135 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mid-term safety and feasibility of an absorbable gelatin film adhesion barrier after laparoscopic colorectal resection

    by Hiroyuki Negishi, Masanori Naito, Kenta Katsumata, Hiro Nishizawa, Yuki Amano, Sota Usui, Hiroshi Nakano, Takehito Otsubo, Shinya Mikami

    Background: With the current increase in life expectancy, the likelihood of undergoing multiple abdominal surgeries has risen. Adhesions from previous operations can prolong operative time, increase the risk of organ injury, and cause adhesive small bowel obstruction. Materials and methods: We evaluated the mid-term safety and feasibility of an absorbable gelatin film adhesion barrier (TENALEAF ® [AGF]; Medical Division, Gunze Limited, Tokyo, Japan) in laparoscopic colorectal resection for malignant tumors. Among 173 patients operated on between March 2022 and December 2023, 150 who received AGF placement beneath the umbilical incision into the peritoneal cavity were analyzed. Results: Tumor sites were the right colon in 48 cases, the left colon in 55, and the rectum in 47. The median operative time was 189.5 minutes (range: 95–544), and blood loss was 5 mL (range: 5–340). AGF was applied successfully in all cases. Postoperative complications included two superficial surgical site infections, one intra-abdominal abscess, one anastomotic leakage, and three cases of paralytic ileus. No adhesive bowel obstruction or AGF-related adverse events were observed during follow-up exceeding 1 year. Conclusion: AGF demonstrated safety and feasibility in preventing postoperative adhesions after laparoscopic colorectal resection. Further follow-up and case accumulation will be required to confirm long-term benefits.

  • Open Access

    Hepatocellular carcinoma converted from atezolizumab and bevacizumab combination therapy: a case report

    by Keisuke Ida, Satoshi Koizumi, Atsuhito Tsuchihashi, Shinjiro Kobayashi, Takehito Otsubo

    Hepatectomy is the curative treatment for hepatocellular carcinoma (HCC), with targeted therapy used when resection is difficult. In this rare case, the tumor shrank with targeted therapy, enabling radical treatment through conversion surgery. The patient, a man in his 70s, developed an 11.5-cm HCC (T3N0M0 Stage III) in the posterior hepatic zone after being virologically negative for hepatitis C. The tumor was near the right portal vein branch, making the liver lobe unresectable due to poor liver function. Upon tumor enlargement, he was treated with atezolizumab and bevacizumab. After 5 courses, the tumor significantly shrank, allowing for complete resection with posterior segment removal. The surgery revealed mostly necrotic tumors with no active cancer cells remaining.

  • Open Access

    Presentation of unruptured right gastric aneurysm due to segmental arterial mediolysis resected laparoscopically: A case report

    by Sae Kimura, Shinya Mikami, Shimpei Takagi, Jin Shimada, Takeharu Enomoto, Takehito Otsubo

    Introduction: Timely diagnosis and treatment of intra-abdominal arterial aneurysms before rupture are highly recommended. We successfully prevented rupture through arterial aneurysm excision, highlighting the importance of the lack of reports on resection before rupture. Case presentation: A 60-year-old male with previous history of ureteral stones presented complaining primarily of left-sided abdominal pain. Computed tomography (CT) revealed a left ureteral stone and incidentally identified a submucosal gastric tumor and right gastric artery aneurysm, leading to referral to our department. Blood tests showed no abnormalities. CT revealed a 23-mm submucosal tumor protruding outward from the middle gastric body wall. A 13-mm aneurysm was observed in the right gastric artery, and no other aneurysms were detected, including intracranially. Upper gastrointestinal endoscopy revealed a smooth elevation covered by normal mucosa in the middle gastric body. Endoscopic ultrasound-fine needle aspiration resulted in a diagnosis of gastrointestinal stromal tumor (GIST) and surgery. We performed simultaneous surgery involving laparoscopic local resection of the gastric GIST and identification and excision of the right gastric artery aneurysm due to its enlargement (7 mm on CT conducted six years ago). The patient's postoperative course was uneventful, and he was discharged on postoperative day 6. Pathological examination confirmed a diagnosis of segmental arterial mediolysis. Discussion: Intra-abdominal arterial aneurysms affect approximately 1 % of the population. Splenic artery aneurysms are the most common at 58.7 %, whereas the gastric artery and gastroepiploic artery account for only 4.7 %. Conclusion: Right gastric artery aneurysms are exceedingly rare, with no reported cases of successful resection before rupture. Highlights:


  • Open Access

    The Influence of Pre-Procedural Imaging and Cystic Duct Cholangiography on Endoscopic Transpapillary Gallbladder Drainage in Acute Cholecystitis

    by Junya Sato, Kazunari Nakahara, Yosuke Michikawa, Ryo Morita, Keigo Suetani, Akihiro Sekine, Yosuke Igarashi, Shinjiro Kobayashi, Takehito Otsubo, Fumio Itoh

    Endoscopic transpapillary gallbladder drainage (ETGBD) for acute cholecystitis is challenging. We evaluated the influence of pre-procedural imaging and cystic duct cholangiography on ETGBD. Patients who underwent ETGBD for acute cholecystitis were retrospectively examined. The rate of gallbladder contrast on cholangiography, the accuracy of cystic duct direction and location by computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP), and the relationship between pre-procedural imaging and the technical success of ETGBD were investigated. A total of 145 patients were enrolled in this study. Gallbladder contrast on cholangiography was observed in 29 patients. The accuracy of cystic duct direction and location (proximal or distal, right or left, and cranial or caudal) by CT were, respectively, 79%, 60%, and 58% by CT and 68%, 55%, and 58% by MRCP. Patients showing gallbladder contrast on cholangiography underwent ETGBD with a significantly shorter procedure time and a lower rate of cystic duct injury. No other factors affecting procedure time, technical success, and cystic duct injury were identified. Pre-procedural evaluation of cystic duct direction and location by CT or MRCP was difficult in patients with acute cholecystitis. Patients who showed gallbladder contrast on cholangiography showed a shorter procedure time and a lower rate of cystic duct injury.


  • Prone “computed tomography hernia study” for the diagnosis of inguinal hernia

    by Natsuko Kamei, Takehito Otsubo, Satoshi Koizumi, Tsuyoshi Morimoto, Yasuo Nakajima

    To improve diagnostic accuracy in cases of a suspected inguinal hernia, we perform a “CT hernia study,” with the patient lying prone to allow decompression of the structures in the inguinal region.


  • Open Access

    Safety-related outcomes of the Japanese Society of Hepato-Biliary-Pancreatic Surgery board certification system for expert surgeons

    by Takehito Otsubo, Shinjiro Kobayashi, Keiji Sano, Takeyuki Misawa, Takehiro Ota, Satoshi Katagiri, Katsuhiko Yanaga, Hiroki Yamaue, Norihiro Kokudo, Michiaki Unno, et al.

    Background We investigated safety‐related outcomes of hepatobiliary pancreatic (HBP) surgeries performed after establishment of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery (JSHBPS) board certification system for expert surgeons. Methods We analyzed post‐HBP surgery mortality data obtained from annual safety reports provided by board‐certified training institutions between 2012 and 2015. Results The 90‐day mortality rate for the 53,929 high‐level HBP surgeries performed at board‐certified training institutions was 1.7%. The 30‐day mortality rates for 2012, 2013, 2014, and 2015 were 0.9%, 0.7%, 0.6%, and 0.6%, respectively, and the 90‐day mortality rates were 2.1%, 1.8%, 1.6%, and 1.3%, respectively, with significant decreases in both. The surgeries with high 4‐year cumulative mortality rates were left hepatic trisectionectomy (10.3%), hepatopancreatectomy (7.6%), liver transplant recipient surgery (6.7%), hepatectomy with extrahepatic bile duct resection (4.6%), and right hepatic trisectionectomy (4.5%). Over the 4‐year period, the number of operations increased, but the 90‐day mortality rates for these surgeries, with the exception of right trisectionectomy, decreased. Conclusions The JSHBPS board certification system for expert surgeons has significantly decreased mortality subsequent to high‐level HBP surgeries. Reducing mortality associated with high‐risk HBP surgeries will be our next challenge.


  • A Study of the Clinical Manifestation of Subclinical Inguinal Hernias

    by Keisuke Ida, Shinjiro Kobayashi, Takehito Otsubo, Natsuko Sasaki, Satoshi Koizumi


  • A Case of Pyogenic Granuloma of the Ileum Presenting with Severe Anemia

    by Taichi Mafune, Shinya Mikami, Junichi Tsuchiya, Asako Fukuoka, Tsunehisa Matsusita, Takeharu Enomoto, Takehito Otsubo

    症例は40歳,男性.黒色便とめまいを認め,前医を受診.血液検査でHb 6.2g/dlと貧血を認め,造影CTで小腸出血が疑われ当院搬送となった.再度施行したCTで造影剤の漏出は認めなかったが,7.5mmの造影効果に富む腫瘤を認め出血源と考えられた.小腸内視鏡では回腸に約10mm大の亜有茎性腫瘤を認めた.腫瘍から出血はなく,その後,貧血の進行を認めなかったため,上下部消化管内視鏡検査で他に出血源がないことを確認し,単孔式腹腔鏡補助下小腸部分切除術を施行.病理検査ではpyogenic granulomaと診断された.Pyogenic granulomaの消化管発生は極めて稀であり,小腸原発の本邦報告は自験例を含めわずか12例に過ぎない.本疾患の多くは高度貧血をきたすため,原因として念頭に置くと共に,ダイナミックCTから小腸内視鏡,そして鏡視下手術といった診断治療のアルゴリズムが有用と思われた.


  • A technique named “vertical array reconstruction (VAR) technique” that can minimize the risk of DGE after PPPD

    by Shinjiro Kobayashi, Kouhei Segami, Hiroyuki Hoshino, Masafumi Katayama, Satoshi Koizumi, Toshihide Imaizumi, Takehito Otsubo

    • 1 June 2015
      • Vol. 62  (140) , 1027-31

    A Novel Approach for Endoscopic Papillary Balloon Dilation with the Guidewire Left in the Pancreatic Duct to Ensure Pancreatic Stenting.

    by Kazunari Nakahara, Chiaki Okuse, Keigo Suetani, Yosuke Michikawa, Shinjiro Kobayasi, Takehito Otsubo, Fumio Itoh

    Endoscopic papillary balloon dilation (EPBD) was reported to be superior for preserving the function of the sphincter of Oddi and to cause fewer late complications than endoscopic sphincterotomy. If the early complication of post-EPBD pancreatitis can be prevented, EPBD might be useful as long-term outcomes. This study assessed the feasibility of a novel EPBD for the purpose of reliable post-EPBD pancreatic stenting. Among 1814 ER-CPs, in 17 patients undergoing biliary cannulation with pancreatic duct guidewire placement method, we performed EPBD with the guidewire left in the pancreatic duct by the two-devices-in-one-channel method. This approach employed in order to ensure pancreatic stenting. Procedures were successfully performed without the guidewire displacement, and pancreatic stents were easily placed in all patients. Post-EPBD pancreatitis occurred in only 1 patient (5.9%), and the severity was mild. Asymptomatic hyperamylasemia occurred in 3 patients (17.6%). There were no other early complications. The mean serum amylase levels (mean ± SD) before, 1 day, and 2 days after procedure were 81.4 ± 61.9, 301.2 ± 273.0, and 220.0 ± 177.6 IU/L. EPBD with a guidewire left in the pancreatic duct is useful method allowing reliable pancreatic stenting and may contribute to the prevention of pancreatitis.